ロード中...

A Novel Method to Compensate for Different Amplification Efficiencies between Patient DNA Samples in Quantitative Real-Time PCR

Quantification of residual disease by real-time polymerase chain reaction (PCR) will become a pivotal tool in the development of patient-directed therapy. In recent years, various protocols to quantify minimal residual disease in leukemia or lymphoma patients have been developed. These assays assume...

詳細記述

保存先:
書誌詳細
主要な著者: Meijerink, Jules, Mandigers, Caroline, van de Locht, Louis, Tönnissen, Evelyn, Goodsaid, Federico, Raemaekers, John
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Investigative Pathology 2001
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1910699/
https://ncbi.nlm.nih.gov/pubmed/11333300
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!